The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients

NCT04321616 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

700

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV Infection
COVID 19
Acute Respiratory Distress Syndrome ARDS

Interventions

DRUG: Hydroxychloroquine
DRUG: Remdesivir
OTHER: (Standard of Care) SoC

Sponsor

Oslo University Hospital